Baxter International (BAX) Capital Expenditures Growth (3y) (2012 - 2026)
Baxter International (BAX) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.62 Bn | 121.41 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 44.86 Bn | 44.04 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 32.89 Bn | 30.65 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 23.19 Bn | 22.76 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 14.08 Bn | 13.52 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | 5.49% |
| 9 | Align Technology | 12.14 Bn | 11.08 Bn | 736.59 Mn | -21.70% |
| 10 | Baxter International | 11.94 Bn | 9.92 Bn | 891.00 Mn | -6.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.01% |
| Dec 31, 2025 | 62.55% |
| Sep 30, 2025 | -11.66% |
| Jun 30, 2025 | 0.72% |
| Mar 31, 2025 | -4.48% |
| Dec 31, 2024 | -10.32% |
| Sep 30, 2024 | -9.20% |
| Jun 30, 2024 | -23.77% |
| Mar 31, 2024 | -13.68% |
| Dec 31, 2023 | -27.05% |
| Sep 30, 2023 | -57.47% |
| Jun 30, 2023 | 4.22% |
| Mar 31, 2023 | -1.38% |
| Dec 31, 2022 | -32.37% |
| Sep 30, 2022 | -1.21% |
| Jun 30, 2022 | -1.87% |
| Mar 31, 2022 | -10.15% |
| Dec 31, 2021 | -3.87% |
| Sep 30, 2021 | 6.07% |
| Jun 30, 2021 | 1.52% |